B Douglas Smith

Professor

1983 …2018
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 34 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Cytarabine Medicine & Life Sciences
Bone Marrow Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
alvocidib Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1983 2018

Developing an instrument to assess patient preferences for benefits and risks of treating acute myeloid leukemia to promote patient-focused drug development

Seo, J., Smith, B. D., Estey, E., Voyard, E., O’ Donoghue, B. & Bridges, J. F. P. Apr 26 2018 (Accepted/In press) In : Current Medical Research and Opinion. p. 1-9 9 p.

Research output: Contribution to journalArticle

Patient Preference
Acute Myeloid Leukemia
Pharmaceutical Preparations
Caregivers
Disease-Free Survival

Pilot trial of K562/GM-CSF whole-cell vaccination in MDS patients

Robinson, T. M., Prince, G. T., Thoburn, C., Warlick, E., Ferguson, A., Kasamon, Y. L., Borrello, I. M., Hess, A. & Smith, B. D. Apr 5 2018 (Accepted/In press) In : Leukemia and Lymphoma. p. 1-11 11 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Granulocyte-Macrophage Colony-Stimulating Factor
Vaccination
Immune System
Homologous Transplantation

Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure-FLT3 Relationship

on behalf of the ETCTN-6745 study team Jul 1 2018 In : Clinical and translational science. 11, 4, p. 435-443 9 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Protein-Tyrosine Kinases
Extracellular Signal-Regulated MAP Kinases
Mitogen-Activated Protein Kinase 6
Metabolites

A phase 1 study of the PARP inhibitor veliparib in combination with temozolomide in acute myeloid leukemia

Gojo, I. , Beumer, J. H. , Pratz, K. W. , McDevitt, M. A. , Baer, M. R. , Blackford, A. L. , Smith, B. D. , Gore, S. D. , Carraway, H. E. , Showel, M. M. , Levis, M. J. , Dezern, A. E. , Gladstone, D. E. , Ji, J. J. , Wang, L. , Kinders, R. J. , Pouquet, M. , Ali-Walbi, I. , Rudek, M. A. , Poh, W. & 5 others Herman, J. G., Karnitz, L. M., Kaufmann, S. H., Chen, A. & Karp, J. E. Feb 1 2017 In : Clinical Cancer Research. 23, 3, p. 697-706 10 p.

Research output: Contribution to journalArticle

temozolomide
Acute Myeloid Leukemia
Methylation
Phosphorylation
Polymers

A phase I study of topotecan, carboplatin and the PARP inhibitor veliparib in acute leukemias, aggressive myeloproliferative neoplasms, and chronic myelomonocytic leukemia

Pratz, K. W., Rudek, M. A., Gojo, I., Litzow, M. R., McDevitt, M. A., Ji, J., Karnitz, L. M., Herman, J. G., Kinders, R. J., Smith, B. D., Gore, S. D., Carraway, H. E., Showel, M. M., Gladstone, D. E., Levis, M. J., Tsai, H. L., Rosner, G., Chen, A., Kaufmann, S. H. & Karp, J. E. Feb 15 2017 In : Clinical Cancer Research. 23, 4, p. 899-907 9 p.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Topotecan
Carboplatin
Leukemia
Neoplasms